Cargando…
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887433/ https://www.ncbi.nlm.nih.gov/pubmed/33614519 http://dx.doi.org/10.3389/fonc.2021.650623 |
| _version_ | 1783651981549633536 |
|---|---|
| author | La Manna, Federico De Menna, Marta Patel, Nikhil Karkampouna, Sofia De Filippo, Maria Rosaria Klima, Irena Kloen, Peter Beimers, Lijkele Thalmann, George N. Pelger, Rob C. M. Jacinto, Estela Kruithof-de Julio, Marianna |
| author_facet | La Manna, Federico De Menna, Marta Patel, Nikhil Karkampouna, Sofia De Filippo, Maria Rosaria Klima, Irena Kloen, Peter Beimers, Lijkele Thalmann, George N. Pelger, Rob C. M. Jacinto, Estela Kruithof-de Julio, Marianna |
| author_sort | La Manna, Federico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7887433 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78874332021-02-18 Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity La Manna, Federico De Menna, Marta Patel, Nikhil Karkampouna, Sofia De Filippo, Maria Rosaria Klima, Irena Kloen, Peter Beimers, Lijkele Thalmann, George N. Pelger, Rob C. M. Jacinto, Estela Kruithof-de Julio, Marianna Front Oncol Oncology Frontiers Media S.A. 2021-02-03 /pmc/articles/PMC7887433/ /pubmed/33614519 http://dx.doi.org/10.3389/fonc.2021.650623 Text en Copyright © 2021 La Manna, De Menna, Patel, Karkampouna, De Filippo, Klima, Kloen, Beimers, Thalmann, Pelger, Jacinto and Kruithof-de Julio https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology La Manna, Federico De Menna, Marta Patel, Nikhil Karkampouna, Sofia De Filippo, Maria Rosaria Klima, Irena Kloen, Peter Beimers, Lijkele Thalmann, George N. Pelger, Rob C. M. Jacinto, Estela Kruithof-de Julio, Marianna Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity |
| title | Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity |
| title_full | Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity |
| title_fullStr | Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity |
| title_full_unstemmed | Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity |
| title_short | Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity |
| title_sort | corrigendum: dual-mtor inhibitor rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887433/ https://www.ncbi.nlm.nih.gov/pubmed/33614519 http://dx.doi.org/10.3389/fonc.2021.650623 |
| work_keys_str_mv | AT lamannafederico corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT demennamarta corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT patelnikhil corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT karkampounasofia corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT defilippomariarosaria corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT klimairena corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT kloenpeter corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT beimerslijkele corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT thalmanngeorgen corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT pelgerrobcm corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT jacintoestela corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity AT kruithofdejuliomarianna corrigendumdualmtorinhibitorrapalink1reducesprostatecancerpatientderivedxenograftgrowthandalterstumorheterogeneity |